Cargando…
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
BACKGROUND: Migraine and depression are highly prevalent and partly overlapping disorders that cause strong limitations in daily life. Patients tend to respond poorly to the therapies available for these diseases. OnabotulinumtoxinA has been proven to be an effective treatment for both migraine and...
Autores principales: | Affatato, Oreste, Moulin, Thiago C., Pisanu, Claudia, Babasieva, Victoria S., Russo, Marco, Aydinlar, Elif I., Torelli, Paola, Chubarev, Vladimir N., Tarasov, Vadim V., Schiöth, Helgi B., Mwinyi, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011097/ https://www.ncbi.nlm.nih.gov/pubmed/33789668 http://dx.doi.org/10.1186/s12967-021-02801-w |
Ejemplares similares
-
The Epigenetics of Migraine
por: Zobdeh, Farzin, et al.
Publicado: (2023) -
Volumetric Differences in Cerebellum and Brainstem in Patients with Migraine: A UK Biobank Study
por: Affatato, Oreste, et al.
Publicado: (2023) -
Major sex differences in migraine prevalence among occupational categories: a cross-sectional study using UK Biobank
por: Affatato, Oreste, et al.
Publicado: (2021) -
OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
por: Sastre Real, María, et al.
Publicado: (2020) -
Assessing volumetric brain differences in migraine and depression patients: a UK Biobank study
por: Affatato, Oreste, et al.
Publicado: (2023)